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Introduction: During all phases of Liver Transplant (LT) process patients tend to develop 
psychological distress. Aims of the present study were to evaluate psychological variables at 
the time of evaluation for listing for LT (T0) and enter in the waitlist for LT (T1). Methods: 
We prospectively enrolled patients admitted at the Bologna Transplant Center between 2017 
and 2018. Patients were compared with an age- and gender- matched control group. 
Significant differences between variables were estimated with non-parametric tests. χ2 or 
Fisher’s exact test was used for categorical variables while Mann-Whitney for continuous 
ones. Changes between T0 and T1 were analyzed with Wilcoxon Test. A p value less than 
0.05 was pondered as noteworthy for all tests. Results: We enrolled 50 patients mainly males 
(68%) with mean age of 57±7 years. A DSM 5 diagnosis was present in one fifth of patients 
and DCPR syndrome in 44%. Enrolled subjects at T0 showed anxiety, depression and somatic 
symptoms. In comparison with control group, experimental one displayed lower scores in 
PCS and MCS of SF-12 (p=0.000, p=0.000, respectively), BC positive refraining, venting, 
instrumental support, humor, behavioural disengagement, emotional support, self-blame (all 
p<0.05) and in ISEL and PTG Scale (all p=0.000). 
Experimental group reported higher scores in the scale of SQ about anxiey, depression, 
somatic symptom and BC substance use score  (all p<0.05).  
Twenty-five patients were admitted in the waitlist (T1). From T0 to T1, there was an increase 
of DSM-5 and DCPR diagnosis. At T1 in comparison with T0, we registered higher scores in 
SQ Hostility subscale (p=0.084) and BC Self distraction (p=0.079). Conclusions: Patients in 
screening for LT show many psychological disorders, often more pronounced than general 
population. From screening to enter into waitlist, many psychological patterns tend to worsen. 
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Organ transplantation represents a consolidated therapeutic tool for many diseases. However, 
transplant recipients often develop psychological distresses such as re-experiencing, 
avoidance, excitement and sense of responsibility towards donor, clinicians and family 
members.  
Liver transplantation (LT) comprises an articulated clinical process. Candidates waiting for 
LT display, by definition, life-threatening disorder needing donor organ for surviving. In this 
context, risk of death waiting transplant is high (4-5% in Italy). When the organ (from living 
or dead donor) becomes available, candidates must undergo to major and harmful surgery, 
followed by short or long intensive care unit hospitalization. After LT, recipients should adapt 
themselves to personalized immunosuppressive protocols and restrictive life-style 
instructions. Additionally, potentially life-threatening complications such as graft rejection of, 
cardiovascular disorders and de novo extra-hepatic cancer might occur (in major percentages 
in comparison with general population). As expected, the quality of life (QoL) of subjects in 
both pre and post-LT period can be negatively modified. Consequently, candidates to LT and 
recipients are at high risk of both somatization and mood disorders. All these phenomena 
generally tend to be reduced during the first year after LT worsening later again. Interestingly, 
both QoL and psychological distress can be reinforced by the continuous medicalization 
embodied by the life-long immunosuppressant therapy.  
It is widely accepted that many social, psychological and psychiatric factors can alter the 
overall outcome of patients during transplant process. In particular, considering heart and 
bone marrow transplant recipients, pre-transplant psychiatric and psychological conditions 
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such as treatment adherence, social supports, coping, seem to influence the post-transplant 
morbidity and mortality.  
Regarding LT, the predictive capacity of pre-transplant psychiatric and psychological factors 
is nowadays discussed. Seeing the impact of psychological variables on the entire transplant 
process, major scientific attention should be deserved to this complex topic. 
Seeing these premises, with the present study, we tried to focus the chief psychological 
patterns of the main steps of the transplant process. We started from pre-LT screening and we 
analyzed the psychological status at the time of enter into the wainting list. Moreover, we 
projected to analyze the phases after LT (early after surgery and at 3, 6, 12, 24 months). 
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1.  PSYCHOSOMATIC  APPROACH AND MEDICAL ILLNESS 
 
1.1 History and evolution of psychosomatic approach 
From	the	beginning	of	the	19th	century,	a	holistic	thought	tradition	starts,	improving	the	
growth	of	the	age	known	as	“romantic	medicine”. In this period, for the first time, Heinroth 
introduced the word “psychosomatics” (1). The main idea of this thought was the introduction 
of a speculative and mystical view with a focus on the unity of body and mind. This period 
was characterized by a new attentions toward both unconscious and dreams and was 
reinforced by philosophers like Schopenhauer (1). In particular, in the middle of the century, 
W. Griesinger and R. Virchow proposed a toughly scientific medicine with remarkable 
interest for the social aspects (1). From the end of the 19th and the beginning of the 20th 
century, the scientific debate focused on the relationship between body and mind has begun to 
spread (2). In this important period, the evolution of philosophy and psychology (W. Wundt, 
1896) to medicine was close. Remarkably, philosophical schools of phenomenology (E. 
Husserl), existence philosophy, hermeneutics (M. Heidegger), psychiatrist (K. Jaspers) and 
internist (V.v. Weizsäcker), all strongly influenced the development of psychosomatic 
medicine. The natural consequence was that interdisciplinary scientific method represented 
one of the principal scientific base of this psychological approach (3). The consequence of the 
cited work was that in 1907, L.v. Krehl stated: “We do not treat diseases, but sick people” (1).  
Psychosomatics continued to develop in 30s thanks to the convergence of the two following 
concepts: psychogenesis and holism (4,5). This confluence represented the very first step of 
psychosomatics medicine (1930-1960) bringing to the concept of “Psychosomatic disease”. 
This latter ultimately embodies a somatic disorder that takes origin by psychological factors 
(6). 
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In the 60s, the contributions of Kissen (7), Engel (8) and Lipowski (9) marked the 
overcoming of concept of psychogenesis. According to Kissen (7), it is conceivable that a 
disease previously considered “psychosomatic” might be “non-psychosomatic” and vice-
versa. The relative weight of psychosocial actors in the disease’s development can easely 
change even within the same disorder. Therefore, it is not legitimate to consider a disease as a 
homogeneous entity. Kissen undoubted had the merit of having shifted the question from 
“what are psychosocial actors in the development of a disease?” to “who are the patient, 
within a given population with a certain disorders, for which the psychosocial variables are of 
primary importance?” (10).  
In 1977, Engel (11) definitively marked the overcoming of the dualism between psychogenic, 
psychosomatic and organic diseases proposing the “biopsychosocial”approach. According to 
this multi-path model, each disorder is the result of multiple biomedical, psychological, social 
and environmental causes. Disorders are not the result of the simple combination of distinct 
etiological factors, but of the complex interaction between them. Later, Lipowsky (5) 
specified the incompatibility of the concept of psychogenesis with the notion of Engel’s 
multicausality and this became the principal postulate of the modern psychosomatic approach 
(12).  
In this renewed cultural context, psychosocial factors can modulate patients’ vulnerability and 
every phases of a disease, from onset to the rehabilitation process. However, their weight may 
vary according to the type of disease, its phases and the single subject (13). 
In general, the personalized and holistic approach should include integration of medical and 
psychological therapies in all phases of illness.  
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Interestingly, the growth of subspecialties such as psychooncology and psychodermatology, 
drives towards the multidisciplinary organization of Health System to overcome artificial 
borders. 
 
1.2 Main patterns of Psychosomatic Medicine 
Psychosomatic Medicine is a wide interdisciplinary field in which biological, psychological, 
and social factors influence the balance between health and disease (14,11,15,16) .  
Psychosomatic approch provides a conceptual framework for the following major issues: 
1. to improve scientific investigations on the role of psychosocial factors affecting individual 
vulnerability, course, and outcome of disease; 
2.  to enhance personalized and holistic approach with the chief role of psychosocial 
assessment; 
3. to develop the integration of psychological and psychiatric therapies in the prevention, 
treatment, and rehabilitation of medical disease; 
4.  to enrich multidisciplinary organization of health care that can overcome the artificial 
boundaries of traditional medical specialties. 
In the past decades, psychosomatic research resulted in an impressive body of knowledge, 
with scientific contributions published in all major medical journals. The application of this 
amount of studies has generated several subdisciplines such as psychooncology, 
psychonephrology, psychoneuroendocrinology, psychoneurogastroenterology, behavioral 
cardiology, psychoimmunology, psychodermatology, and others (e.g. transplant psychology).  
Clinical services, scientific societies, and medical journals grow as natural consequence (17) 
The Diagnostic Criteria for Psychosomatic Research (DCPR) can help to translate the 
psychosocial variables that came from psychosomatic research, into working tools. The 
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DCPR, introduced in 1995 (18) can be useful in many clinical settings. Their value in the 
psychosomatic assessment, regardless of the ‘organic’ or ‘functional’ nature of the illness, has 
been widely documented (19-21). 
Many factors seem to modulate the individual vulnerability to disease. In particular, the role 
of early developmental factors in the disorders’ susceptibility has been a frequent subject of 
psychological reseach (22). In fact, the stressfull life events may be followed by many health 
issues. The introduction of structured methods of data collection and control groups, has 
allowed to confirm the strong association between life events and medical disorders such as 
endocrine, cardiovascular, respiratory, gastrointestinal, autoimmune, skin, and neoplastic 
disease (23,24) . 
McEwen (25) proposed a formulation of the relationship between stress and the processes 
leading to disease based on the concept of allostasis that is the ability of the organism to 
achieve stability through change. According to this view, allostatic load reflects the 
cumulative effects of stressful experiences in daily life. 
In particular, behaviors that can more often impact the health, concern physical activity, diet, 
sleep, smoking, drinking, and drug consumption. These behavioral factors are interrelated and 
can have a synergistic effect on both morbidity and mortality (26,27). It must be underlined 
that to achieve a wide change of an unhealthy behavior is particuarly difficult. For instance, 
about 75% of patients with cardiovascular diseases were unable to change their bad habits 
despite the fact that they were informed about the risk factors (28). Indeed, knowledge about 
the risks associated with health-damaging behaviors is not necessarily associated with their 
avoidance. 
Social relationships such as social network composition, social support, frequency of social 
interactions, and the experience of loneliness and isolation have been clearly associated to 
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both physical and mental health (29). In this way, prospective studies substantiated the role of 
social support in relation to mortality, psychiatric and physical morbidity, recovery, and 
adjustment to chronic disease (30). Interventions designed to improve the social environment 
and interpersonal relationships, are effective in facilitating psychosocial adjustment to 
medical disorders (30). 
Religiosity and spirituality (broadly defined as any feelings, thoughts, experiences, and 
behaviors that arise from the search for the ‘sacred’) have been a matter of growing interest in 
epidemiological research (31). Remarkably, religiosity displays positive effect on survival 
independently from behavioral factors, negative affect, and degree of social support (31,32). 
Assessment of psychosocial factors potentially influencing individual vulnerability to illness 
is often omitted by the primary care physician or the medical specialist (16). This is the result 
of a reductionist approach that has deeply influenced medicine (16,33,34,23,11,35). 
Psychosocial variables affecting illness vulnerability may encompass a temporal relationship 
between life events and symptom onset or relapse; the presence of grief reactions, including 
the loss of a body part or bodily function; the perception by a person of environment as 
exceeding his/her resources (i.e. allostatic load/overload). Patients often deny a relationship 
between their allostatic load and symptomatology. In fact, they are unaware of the latency 
between stress accumulation and symptom onset (“I had bowel symptoms yesterday, which 
was an easy day at work, and not the previous days, which were awful”). Interestingly, 
symptom worsening during week-ends and vacation time is a common manifestation of this 
latency (36); interpersonal relationships providing a buffering role for stress; psychological 
assets and well-being. 
The modality of information may be crucial in managing patients with unexplained somatic 
symptoms (37) to avoid difficult patient-doctor relationships (38). 
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Psychosomatic medicine pioneered the self-rated evaluation of psychological status in 
medical conditions (39). 
Rating scales such as the Symptom Check List 90 (40), the Hospital Anxiety and Depression 
Scale (41), and the Symptom Questionnaire (42), were extensively used in medical settings 
(43). Evaluations of distress and wellbeing anticipated interest in quality of life assessments 
and patient-reported outcomes. Notably, there are poor data about definition of quality of life. 
Indeed, research in this area seeks essentially two kinds of information: the functional status 
of the individual and the patient’s appraisal of his/her own health. Indeed, the subjective 
perception of health status (e.g. lack of well-being, demoralization, difficulties fulfilling 
personal and family responsibilities) represents a relevant element that can influence the 
patients’ outcome (44-46). Psychosomatic and clinimetric approach emphatize the relevance 
of patient-reported outcomes (47). In this way, any report coming directly from patients about 
how they function or feel in relation to a health condition or its therapy is important (48,49). 
Psychiatric illness appears to be strongly associated with physical diseases. Mental disorders 
increase the risk for communicable and noncommunicable diseases and many health 
conditions increase the risk for mental disturbances. Notably, comorbidity can complicate 
recognition and treatment of medical disorders (50). Furthermore, psychiatric disturbances 
can worsen the course of medical disease in terms of response to treatment and prognosis 
(50,51). 
The main levels of psychosomatic intervention are the following:  
1. prevention strategies and health behavior modifications: switching the general population 
to healthy lifestyles would be a major source of prevention for the most prevalent conditions 
such as diabetes, obesity, and cardiovascular illness (52-55); 
2. type of approach to patient care; 
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3. specific psychotherapeutic and psychopharmacological management in the setting of 
medical disease (fava1). 
Finally, there have been major transformations in health care needs (56-58). The traditional 
medical specialties, based mostly on organ systems (e.g. cardiology, gastroenterology), 
appear to be more and more inadequate in dealing with symptoms and problems that cut 
across organ system subdivisions and require a comprehensive approach. 
Multidisciplinary services have been developed within specialties and subspecialties such as 
oncology, cardiology, dermatology, gynecology, nephrology, gastroenterology, organ 
transplantation, and endocrinology (59-62). Such services may be operated by various 
specialists (group approaches) or by a single specialist with a multidisciplinary background. 
These services are addressed complaints that fall between disciplines and require a 
psychosomatic approach. 
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2. LIVER AND MULTI-ORGAN TRANSPLANTATION PROCESS 
 
2.1 Evolution of liver transplantation 
Transplant process includes selection of candidates, long waiting, major surgical act, fine 
immunological balance between transplanted tissue or organ and recipient. Seen the 
complexity of this process, it is not surprising that transplantation needed decades to develop 
and to become a consolidated life-saving surgical act. History of transplantation began in 
1968, when Sir Roy Calne completed the first human orthotopic liver transplant (LT) in 
Europe (Cambridge) (63). Few months later, in North-America, Thomas Starzl made the first 
effective human LT (64). Then, LT quickly advanced becoming the leading therapy for both 
acute and chronic liver failure, with more than 100,000 procedures performed (data from 
European registry: http://www.eltr.org). 
According to the conventional or ‘‘Standard” LT technique (whole liver graft), the liver graft 
is implanted in the right upper quadrant, in the place previously occupied by the diseased 
liver. The surgical technique differs according to whether or not the recipient’s inferior vena 
cava (IVC) is conserved. In most European countries, the piggy-back technique is employed, 
which involves the preservation of the native IVC (65). Anastomosis of the donor’s 
suprahepatic IVC to the recipient’s three hepatic veins is made (Figure 1), as well as 
rebuilding of the portal vein, hepatic artery and biliary tree, using duct-to-duct anastomosis 
between the donor’s main biliary tract and the recipient’s one (66). When the recipients IVC 






Figure 1. Liver Transplantation with piggy-back technique. Anastomosis of the recipient three hepatic vein 
union with the donor inferior vena cava (IVC).  
 
 
LT is indicated in patients with end-stage liver disease, in patients with hepatocellular 
carcinoma (HCC) and in subjects with acute liver failure. In particular, cirrhosis represents 
the most common indication for LT worldwide (in adults). The main indications for LT in 





Figure 2. Primary diseases leading to liver transplantation in Europe (time period: year 1988-2011) (data from 
European registry: http://www.eltr.org). *Others: Budd-Chiari: 792. Benign Liver Tumours or polycystic disease: 
1228. Parasic diseases: 80. Other liver disease: 1304. 
 
 
In particular, in the last 25 years survival percentages considerably increased. Today, we can 
register an overall 1-year survival of 96% and a 10-year survival of 71% with some 




Figure 3. Overall result in liver transplantation by indication (data from European registry: http://www.eltr.org).  
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These great achievements represent consequences of continues surgical, clinical and 
pharmacological advances (69). In these last years, indications for LT have been expanded 
considering the efficacy of this therapeutic approach but organ shortage and the consequent 
high waitlist mortality are actually the true challenges of the transplant community.  
 
2.2 Clinical issues of liver transplant process 
Main aim of LT should be to lengthen life expectancy beyond the natural history of 
underlying liver disease (with achievement of so called “transplant benefit”) but also to 
improve patients’ quality of life (QoL). Patients should be designated if estimated survival in 
the absence of LT is 1 year or less, or if the patient had an unacceptable QoL because of liver 
disease. A detailed medical evaluation is performed to ensure the feasibility of LT (pre-LT 
screening). 
The ideal moment for referring patients to Transplant Center is the first decompensation of 
liver disease (variceal bleeding, ascites, hepatorenal syndrome and encephalopathy). On the 
other hand, acute liver failure is an urgent indication to LT (70).  
The timing of LT is a main clinical point. In fact, patients with end-stage liver disease should 
be transplanted before some life-threatening systemic complications occur. At the same time, 
candidates should not be transplanted too early (for the risk of not substantial transplant 
benefit).  
In the past years, priority on the waiting list was based mainly on the waiting time. This not 
objective criterion, since 2002, was replaced by the model of end-stage liver disease (MELD) 
score (based on objective measures such as creatinine, bilirubin and international normalized 
ratio) (71). The MELD represents a very good index of three-month mortality. Indeed, 
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according to this system actually used in the vast part of Transplant Center, patients’ priority 
depends only by disease severity (72). Remarkably, in subjects with MELD <14, 1-year 
survival was lower with LT than without it (73). Consequently, a MELD score >15 is 
indicated to list patients with cirrhosis. On the other hand, very sick patients (MELD >30) 
both morbidity and mortality are very high making indication to LT at least doubtful. 
MELD score influences the allocation of grafts in many European countries including Italy. 
Nevertheless, the definitive decision for allocation has to be based on many further 
parameters besides MELD including liver-donor match and local-regional allocation systems. 
Hepatitis C virus (HCV)-related liver disease represents the main indication for LT 
worldwide. Today, with development of new direct-acting antivirals, anti-HCV therapy is 
highly effective and safe. Indeed, at least in developed countries, in the next years HCV will 
tend to decrease as indication for LT (74). In particular, the HCV replication at the time of 
LT, does not represent a contraindication, but antiviral treatment will be indicated as soon as 
possible after surgery. 
Alcoholic liver disease represents the other most common indications of LT in Western 
countries (75). LT for alcoholic cirrhosis has a favourable outcome, similar or better than 
other aetiologies (76). Several centres developed an evaluation process based on medical and 
psychiatric criteria to better determine patients that would mostly benefit from the LT. 
Alcohol abstinence of at least 6 months in order to evaluate the need and timing of LT and to 
obtain a better control of alcoholism, is usually required (the so called “6-month rule”). This 
interval is neither a consensus nor an absolute requirement. The risk of alcohol use recidivism 
is estimated between 15 to 40% depending on the series and how recurrence of alcoholism is 
defined. If the risk of recurrence might be related to the length of abstinence is debated (77). 
The interest of the 6-month abstinence rule is double: a) abstinence can lead to significant 
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improvement of liver function avoiding the need for transplantation; and b) this period of 
abstinence is an opportunity to assess the patient compliance and to build a whole psyco-
social process of support. However, there are strong limitations to this rule: a) the duration of 
abstinence before LT was not found to be related to the risk of recidivism in many studies; b) 
the improvement in liver function occurred mainly during the first three months of abstinence; 
c) during this period some patients with no risk of recidivism will die; d) several authors and 
today the main scientific associations guidelines, consider that the risk of recidivism is more 
related to psychosocial factors than to the duration of abstinence itself. Therefore, the most of 
scientific community has advocated breaking the 6-month rule for selection of canidates (78). 
Acute alcoholic hepatitis (AAH) has been considered an absolute contraindication to LT on 
the grounds that patients with this disorder have been drinking recently and that period of 
abstinence will allow many to recover. Unfortunately, many patients die during this time 
interval. Patients who do not recover within the first three month abstinence are unlikely to 
survive (79). If the AAH is severe (Maddrey’s score >32), treatment with steroids can 
improve the outcome (80). The Lille score allows an evaluation at day 7 after therapy 
introduction, if it is over 0.45, the expected survival is below 30% at 6 months (81).  
In a recent multicentre French study, patients with first episode of severe AAH resistant to 
steroids, favourable psychosocial environment and good addiction disease consultation, have 
been transplanted resulting with a dramatic improvement in survival in comparison to their 
spontaneous expected survival. Moreover, at 2 years from the LT, a low rate of recidivism has 
been registered (82). This study needs confirmation before achieving a consensus on the 
indication of LT in relation with abstinence duration. However, it emphasises the significance 
of psychosocial management of these patients to ensure long-term success of LT.  
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In the setting of the metabolic or insulin resistance syndrome, NAFLD (Non-Alcoholic liver 
desease) and NASH (Non-alcoholic steatohepatitis) are becoming increasingly common 
medical problems in the developed world. Therefore, NASH-related cirrhosis is today a new 
strong indication for LT (83). 
 
2.3 Psychological and psychiatric aspects 
Transplantation must be intended as a complex process made up of different phases which 
include communication with the patient (and family); the permanence on the waiting list (of 
varying length); the post-operative hospitalization period and the short-, medium- and long-
term post-discharge day care check-up. 
Transplanted population shows changes in their relationships with family members and 
medical staff since they tend to experience the ritual of death and the rebirth to a new life 
(84). In particular, regaining physical integrity is often complex because patients show 
difficulties in accepting the new organ as part of the own body and not as a separate identity. 
Returning to physical activity, social relationships and work after transplant may be 
associated with psychopathological distress (85,86). 
Indeed, the goal of transplantation should not be only to enhance patients’ survival, but also to 
offer the same state of health that they enjoyed before the onset of liver disease. This complex 
achievement can be reach through a balance between the functional efficiency of the graft and 
the patient’s psychological and physical integrity (87,88). 
Organ transplantation is no longer a novel event in many societies. Indeed, social 
constructions in relation to transplantation itself have emerged in both the medical world and 
the wider community. It would be important to conceive the transplant as an exchange and a 
sort of gift. In this way, we can reinforce the idea of donated organ as “gift of life” (89). Fox 
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and Swazey argued that this concept has become so pervasive that it can be considered the 
basis for the foundation of all transplantation discourses rest (i.e., medical, organ procurement 
agencies, and the general public). Many authors reported that the concept of transplant as a 
gift fails to encompass the myriad psychosocial complexities involved in the transfer of an 
organ from one person to another (90,91). Shaw (92) suggested that gift-of-life rhetoric might 
lead recipients to develop a sort of material estimation of transplant experience instead of a 
true elaboration of the transplant itself. 
Some authors suggested that donor organs might be better thought of in a different light, 
perhaps as donations rather than gifts (93). Both understandings are found in social discourses 
around organ transplantation. Even though this distinction might seem purely semantic, we 
contend that it has relevant implications. O’Brein (94) developed an interview analysis of 13 
heart transplant patients with the main aim of exploring how the lived experiences of organ 
transplantation can be grounded in social discourses about organ donation, gift of life, and 
gratitude. Authors reported that there are relevant differences between organ-as-gift and 
organ-as-donation. In particular, the concept of organ-as-donation can favor the post-
transplant gratitude and, ultimately, the development of meaning(s) gleaned from the 
transplant experience. 
 
2.3.1 Pre-transplant psychosocial status  
LT recipients can develop many psychological distresses such as re-experiencing, avoidance, 
excitement and sense of responsibility toward donor, clinicians and family members (95-99). 
In particular, LT includes a complex and articulated clinical process (98). Candidates waiting 
for LT by definition present life-threatening disease needing donor organ for surviving 
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(100,101). When the organ becomes available, patients undergo major surgery and then they 
have to bear short or long intensive care unit hospitalization. After LT, recipients should 
adapt to immunosuppressive drugs and restrictive life-style rules. Furthermore, potentially 
life-threatening disorders such as graft rejection, cardiovascular diseases and de novo extra-
hepatic malignancies might occur. As expected, the QoL of patients in both pre and post-LT 
period can be negatively altered (102). In this regard, we reported in Figure 4 the main factors 




Figure 4. Main factors influencing the quality of life of patients during the transplant process. We detected the 
following main macro-categories: social context, patient psychological patterns, underlying liver disease and 
features correlated to transplant. Hashtag indicates the effect on pre-transplant quality of life; asterisk, on post 
transplant quality of life. HCV, hepatitis C virus.  
Figure from: Golfieri L, Gitto S, Vukotic R, Andreone P, Marra F, Morelli MC, Cescon M, Grandi S. Impact of 
psychosocial status on liver transplant process. Annals of Hepatology 2019.
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Becouse of the same considerations, candidates to LT and recipients are at high risk of both 
somatization and mood disorders. All these conditions tend to be attenuated during the first 
year after LT worsening later again. Interestingly, both QoL and psychopathology can be 
reinforced by the continuous medicalization well embodied by the immunosuppressive drugs 
(103). In particular, social, psychological and psychiatric factors might impact the overall 
prognosis of transplant recipients (104,105,85). Considering the LT setting, the predictive 
capacity of pre-transplant psychiatric and psychological factors is actually debated. 
During the pre-LT screening process, social, psychological and psychiatric assessments are 
usually conducted. The aim is to exclude major psychiatric illness (such as schizophrenia) and 
to analyze the possible lack of adherence associated to active illicit drugs use, active alcohol 
consumption and deficiency of social support (106,107).  
The etiology of liver disease is a relevant risk factor for impairment QoL and mental disorder. 
It is well known that HCV can alter the QoL showing deleterious impact on mental health and 
physical well-being (108,109). HCV positive patients tend to develop fatigue, irritability, 
general disconfort, abdominal pain, joint pain and headache that may impact psychological 
status and particularly QoL (110,111). HCV negatively modifies the post-LT condition since 
HCV positive recipients can show higher rates of depression symptoms in comparison with 
other etiologies (112). Also subjects with alcohol-related liver disease deserve specific selec-
tion. In fact, alcohol use disorder (AUD) is associated in about 30% of cases with a mood 
disorder (113,114). In particular, the presence of negative and passive coping behavior such 
as anacceptance-resignation strategy is a main reason of mental health weakening leading to 
an altered insight of physical functioning and a drop of global QoL (115). 
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2.3.2 Impact of psychological distress on post-transplant outcome 
In the immediate post-transplant period, many psychiatric problems can arise which may 
necessitate the involvement of the psychiatrist/mental health professional. Delirium (also 
referred to as encephalopathy) is reported to be the most common neuropsychiatric problem 
after the transplant surgery (116-118). It is characterized by confusion, disorientation, 
fluctuation in consciousness and agitation, and poses as a management difficulty in the 
intensive care unit. Development of encephalopathy has been associated with higher rates of 
mortality (118). The causes of delirium can be varied in a patient of LT and may include 
concurrent brain pathological processes, e.g. infection or bleed; effects of vasoconstriction 
secondary to immunosuppressive medications (especially cyclosporine and Tacrolimus); and 
central nervous system pharmacodynamic effects of the immunosuppressive medications 
(119).  Evaluation of delirium during this period of time must include careful medical 
examination of the patient and review of the medications and laboratory studies. 
Neuroimaging, EEG recording, and lumbar puncture can also provide valuable information in 
evaluating the cause of delirium (120). 
In the context of organ transplantation, depression is surely the most studied mental disease. 
Considering the general population, depression represents not only a significant determinant 
of QoL (121) but also a relevant predictor of increased clinical burden and poor treatment 
adherence (122). Few studies are accessible about pre-transplant psychological predictors of 
post-LT outcome and particularly on the possible role of pre-LT depression. However, 
depression is present in 15% of candidates waiting for LT (123).  
Kanwal (124) showed that cirrhotic patients with low QoL display worse survival respect to 
the others, even after adjusting for solid clinical factors such as MELD score. Authors 
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demonstrated that different levels of Short Form Liver Disease Quality of Life independently 
predicted overall patients’ mortality. Interestingly, patients with pre-LT depression-like 
symptoms show high risk of post-LT overt depression (125). Young age, lack of spouse and 
unemployment were predictors of post-transplant depression (126). Also other psychological 
alterations can negatively impact the post-LT mental health. Pre-LT anxiety and neuroticism 
were associated with worse psychosocial outcome at 1 year from the transplant (127). Pre-
transplant vulnerability can forecast the onset of mental status distress after transplantation 
(128). Additionally, pre-LT maladaptive coping mechanism, disregulation, hostility, lack of 
effective social support, were associated with worse QoL and mood at 1 year after transplant 
(129). Corruble (130) demonstrated that depressive symptoms on waitlist were associated to 
3- to 4-fold increase risk of graft failure and mortality, independently from all the other main 
drivers of post-LT outcome such as age, gender or primary liver disease diagnosis. 
Interestingly, as possible clarification, the authors suggested that transplant recipients with 
depressive symptoms might be better competent to face psychological distress that commonly 
arises after transplant. On the other hand, Rogal et al. (131) reported that pre-LT depression 
did not directly influence theclinical outcome in terms of graft rejection and mortality. 
However, patients with depression needed more often psychiatric support in the post-LT 
period (37% vs. 18%). Moreover, patients on effective antidepressant therapy at the time of 
transplant displayed lower rate of acute cellular rejection in comparison with untreated 
patients (13% vs. 40%). Indeed, authors suggested that underestimated or untreated 
depression could harmfully impact the post-LT clinical outcome. The same authors (132) 
reinforced the message analyzing the long-term transplant outcome proving that the efficient 
treatment of psychiatric condition might influence patient survival more than the consolidated 
predictors such as HCV clearance, low MELD score and young donor age. Telles-Correia 
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(133) showed that pre-transplant solid social support was a significant predictor of 1-year 
post-LT survival while presence of pre-LT neuroticism was associated with higher post-LT 
mortality.  
 
2.3.3 Transplantation as opportunity: the post-traumatic growth 
After transplantation, according to some authors patients felt a new life and believed that the new 
organ gave them a new opportunity. According to other studies, patients passed through various 
phases after surgery the so-called “phases of toleration to the disease.” Facing the disease and 
reformation occurred after transplantation (134). However, according to the study by Kaba, 
patients can accept the new organ with relevant difficulties (135).  
It was found that transplanted patients had more time to spend with their family members and 
children in the in comparison with the past. After transplantation, they happily spend their time to 
meet their family members’ needs (136).  
The patients experienced a fruitful period of life after transplantation, returned to work, in-
creased the level of their activities and enjoyed their life. In particular, patients’ abilities to 
return to normal life and recover from the disease improve spiritual well-being and enjoy life 
after transplantation (137). 
Under these circumstances, the concept of post-traumatic growth, which is the idea that 
stressful life events may create the opportunity to activate one’s resources, leading to a higher 
level of functioning than before, is highly relevant. This concept, developed by Tedeschi and 
Calhoun (138) is associated with the positive psychology movement. Basically, post-
traumatic growth can be a protective factor (138,139) that enables patients to reframe threats 
into challenges, thereby strengthening their psychological wellbeing (140,135).  Previous 
studies found high levels of post-traumatic growth after lung transplantation (141) that was 
even higher than those observed in patients suffering from chronic heart disease, cancer or 
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HIV. High levels of post-traumatic growth have also been found after haematopoietic stem 
cell transplantation (HSCT) (142).  However, lung transplantation and HSCT have markedly 
lower survival rates than LT (136) that may have important implications regarding 
traumatisation as well as post-traumatic growth. To the best of our knowledge, there are only 
two previous studies dealing with post-traumatic growth in LT recipients (140,135). 
Anand-Kumar et al. (143) reported that transplanted patients perceived “advantages” from the 
transplantation experience accordingly with PTG. In particular, the transplantation experience 
underlies a change in life philosophy, self-perception and relationships with others (143,144). 
Within the field of post-traumatic growth, changes in life philosophy might reflect a 
modification in the perception of life itself (increased appreciation of life, family and friends, 
increased spirituality) (145). According with the PTG Theory, overcoming a stressful life-
event, such as undergoing an organ transplant, can give the opportunity to improve the ability 
to relate with others and improves the sense of gratitude (146). 
Scientific literature reported that some patients attribute an improvement in the perception of 
their own physical and mental health, along with a greater awareness in the management of 
these topics, to the transplantation experience. These elements represent a core component of 
the PTG: augmentation of personal strength and improvement of the capability of overcoming 
the specific challenges posed by the trauma. Surviving such traumatic experiences may 
promote planning abilities and the development of strategies for handling life-threatening 
negative events in the future, such as rejections, recurring infections, immunosuppressant 
therapy side-effects, re-transplant (145). 
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Speaking about the relationship between PTG and transplant, Tallman (147) observed a group 
of marrow transplant patients reporting high levels of physical, spiritual and psychological 
well-being as well as PTG, connected with factors like female gender, older age, levels of 
optimism and the presence of social support.  
In a longitudinal study, Scrignaro et al (148) used a sample of 100 LT patients from the 
outpatient population. Participants filled in the Posttraumatic Growth Inventory (PTGI) and 
group identification scales at two different times 24 months apart. The results showed that 
post-traumatic growth positively predicted identification with the family group and the 
transplantee group over time. Zięba (149) examined 48 LT recipients about 10 weeks after 
surgery. Recipients told two stories about freely chosen important events in their lives. The 
measurement of post-traumatic growth 10–12 months later showed that the affective tone of 
the narratives was associated with the level of post-traumatic growth, and that positive 
affective tone was related to greater post-traumatic growth.  
Both studies unveiled potentially important mechanisms by which post-traumatic growth may 
positively affect well-being. However, the association of post-traumatic growth and QoL 
which is of central importance in the present study, was not dealt with in those papers. 
Post-traumatic growth is also highly relevant for close relatives, particularly caregivers of the 
LT recipient, who is dependent lifelong on medical care and intensive social support. In this 
setting, the caregiver is confronted with the profound impact of LT on his or her personal life 
and its challenging implications (150,151). There is growing evidence regarding the great 
amount of stress in caregivers before and after LT, which may even result in symptoms of 
post-traumatic stress (152,153). The close mutual relationship between transplant recipient 
and caregiver makes it understandable that caregiver stress may also negatively affect the 
patient’s AoL and therapy adherence.  
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Pérez-san-Gregorio MA (154) demonstrated that regardless of the time elapsed since LT, 
recipients showed more post-traumatic growth than their caregivers. A high level of post-
traumatic growth was associated with high levels of specific aspects of QoL such as vitality, 
whereas a longer time span since transplantation was related to more pain. Compared with the 
general population, recipients generally showed lower quality of life, except in patients with 
high levels of post-traumatic growth. In these cases specific dimensions of quality of life, 
such as bodily pain, vitality, mental health and general health, equalled or even surpassed 
scores in the general population. Facilitation of post-traumatic growth after LT may be crucial 
to ensure long-term quality of life in recipients. 
 
2.3.4 Immunosuppressive drug adherence  
The lack of compliance can negatively alter both QoL and clinical outcome of transplant 
recipients. In fact, it is the most important driver of graft rejection (155). Correct selection of 
candidates to organ transplant estimates the compliant behavior before surgery (155). In 
particular, a psychotherapeutic support program for candidates to LT might increase the 
compliance to medical issues thanks to more efficient adaption to the transplant process 
(156). However, data about the predictive ability of pre-LT psychosocial condition regarding 
the immunosuppressive therapy adherence are discordant. Rodrigue (157) reported that pre-
LT both mood disorder and social support instability amplified the risk of non-adherence. 
More recently, Lieber (158) reported high rates of inadequate compliance (50%). However, 





2.3.5 Role of psychologist in the transplant process  
The pre-LT psychological evalutation might be significant for the evaluation of LT candidacy 
and for the enhancement of post-LT clinical outcome (106). Candidates on waitlist often 
develop fears related to surgery and depression symptoms that can negatively affect 
functional capacity, social context, economic situation, global mental health status and post-
LT outcome (159). The presence of pre-LT mood disorder, the lack of social support, the 
substance misuse and the alcohol habit, can predict a worsening of post-transplant mental and 
physical morbidity (160). In this context, targeted psychological intervention can help to 
support the recovery process improving QoL and observance to clinical indications (159). 
Moreover, psychosocial interventions can help patients to reduce illness-related fear but also 
symptoms of anxiety and depression (161). Outstandingly, the psychological intervention has 
to be fully integrated in a multidisciplinary clinical approach with the participation of all the 
main professional figures of the LT process (surgeons, hepatologists and psychologists) who 
should collaborate, interchange information and face together the chief clinical events of the 
transplant process. In particular, in the context of LT, only a total intervention results to be 
effective as diagnostic and therapeutic tool (155). The psychological support and care can be 
instruments for early diagnosis and fast treatment but also elements of empathy toward the 
entire clinical transplant team. In this way, the medical approach alone might favor the 
development of negative psychological reactions such as somatization (159). One of the main 
aims of the transplant psychologist should be the achievement of active coping strategy. As 
just reported, coping can be defined as all capacities used to face stressful circumstances. The 
assessment of coping strategies should be studied during the transplant process encouraging 
patients to use of action-oriented methods and discourage the passive reactions that negatively 
alter the prognosis (162,163). Telles-Correia (133) demonstrated that active coping is a 
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significant predictor of short hospitalization after LT. Active coping, social support and 
multidisciplinary approach might help patients to acquire psychological positive change after 
LT (164). The relevance of social support has been confirmed in many transplant settings 
including LT (147). LT candidates with anxious family members tend touse to a lesser extent 
effective coping strategies such as active fight-ing, self-control/emotional control and seeking 
for social support (165). Caregivers of LT candidates often show psychological problems and 
stressors such as doubts about emergency situations (42.6%), mood swings (29.5%), food and 
medications (27.9%). In general, a quarter of the caregivers feel themselves 
inadequate/insufficient for their role. Seeing the relevance of the social support, sustenance 
measures and caregiver-dedicated training should be applied in all transplant centers (166). 
Multidisciplinary team should help patients to develop positive attitude toward transplant 
process. In particular, transplant recipients should get a post-traumatic growth that is a 
positive psychological modification consequent to an adverselife experience. Pérez-San-
Gregorio (162) analyzed the predictors of post-traumatic growth (assessed with Posttrau-
matic Growth Inventory) in LT recipients demonstrating that active coping, instrumental 
support, emotional support and acceptance, were associated to a major growth. Transplant 
surely is a stressful event but it can lead to major confidence in own capacities particularly 
regarding the management of difficulties. Organ transplantation can favor the aptitude to 
organize and plan the everyday activities and facilitate new adaptive strategies (167). Again 
Pérez-San-Gregorio (168) studied the post-traumatic growth of caregivers of LT recipients. 
The authors demonstrated that, also in the caregivers, positive coping strategy correlated with 
a better post-traumatic growth. 
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3. THE BIOPSYCHOSOCIAL APPROACH IN LIVER AND MULTI-ORGAN 
TRANSPLANT : ASSESSMENT OF THE OUTCOME PREDICTORS 
 
3.1 Introduction 
LT represents the treatment option for patients with acute liver failure, end-stage liver disease, 
and HCC (169). Today, thanks to the effective use of immunosuppressant drugs, the growing 
surgical techniques, and the continuous improvement of post-surgery management, 
satisfactory 5- and 10-year survival rates after LT can be reached (f.e. for alcohol-related 
cirrhosis, 74% and 60%, respectively) (170-173).  
Notably, LT process can often lead to psychological distress (174-176). In the last years, the 
scientific and clinical attention toward the mental health status of patients into the Transplant 
Program is increasing (177). In patients waiting for LT, commonly encountered mental 
disorders include substance abuse and anxiety (178). After LT, psychological diseases such as 
depression and stress disorder can affect both drug adherence and QoL (179). Ultimately, LT-
related mental diseases can affect the clinical outcome of patients receiving LT (132). 
 Psychosomatics research highlighted how psychosocial factors may have a predictive value 
regarding to clinical outcome of LT recipients (180). 
Clinical studies reported that pre-transplant psychological and clinical variables (such as 
compliance, life-style, social support, coping, presence of anxious-depressive suffering) might 
predict the psychosocial prognosis and influence both post-LT morbidity and mortality (181-
182). 
Some authors claimed that the pre-LT psychological distress and psychiatric condition may 
be predictors of insufficient psychosocial adaptation (181-183), organ rejection (184) and 
mortality (184-186,112). 
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In a clinical context where the life-long immunosuppressant therapy represents the backbone 
of the medical therapy, compliance represents a noteworthy clinical challange. Moreover, 
inter-specialist cooperation is an essential therapeutic element in the transplantation surgery 
framework (155).  
 
3.2 General study Design 
The study should have included several steps. The first time point was the screening 
evaluation for the LT (T0). Subsequently, enrolled patients should be re-evaluated during the 
following phases: at the signing of the Informed Consent for the active insertion in the 
waiting list (T1), soon after the LT (T2), and at 3 (T3), 6 (T4), 12 (T5), 24 months (T6) form 
the LT. In addition, the test sample was compared (at T0) with a group of subjects selected 
from the general population to assess the psychological impact of pre-LT screening. 
The identification of psychosocial variables that can impact the long-term clinical outcome 
may represent a starting point for the design and implementation of psychological-clinical 
support strategies for patients into the tranplant process. 
We speculated that pre-LT psychological distress and psychiatric disorder might decrease 
compliance to therapeutic protocols (pharmacotherapy, life-styles) with consequent negative 
impact on both morbidity and mortality. 
Furthermore, we hypothesized that positive psychological indices, such as post-traumatic 






3.3 Study 1  
3.3.1 Objective 
The objective of the study 1 was to evaluate psychological and psychosomatic distress, 
coping, social support, QoL, post-traumatic growth and sense of gratitude at the time of 
evaluation for listing for LT (T0 time point). Moreover, to compare enrolled patients at T0 
and subjects selected from the general population (control group).  
 
3.3.2 Methods 
- Study population 
The study was conducted on 2 samples of subjects: 
- consecutive patients admitted at the Liver Transplantation and Multiorgan Organ 
Transplants Unit (Prof. M. Cescon) and Medicine for the Treatment of Severe Organ 
Failures (Dr MC. Morelli) - S. Orsola Hospital (Bologna, Italy) for screening to enter 
in LT waiting list between June 2017 and June 2018; 
- control group coming from general population (matched for gender, age and 
sociodemographic variables). 
Patients are consecutively enrolled after signing the informed consent. 
We established the following exclusion criteria (conditions that make the psychological 
evalutations unfeasible): 
- hepatic encephalopathy (degree ≥2 according to the “West Haven criteria” (173); 
- Mini Mental State Examination (MMSE) <24 (187); 
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- Schizophrenic spectrum disorders and other psychotic disorders in active phase 
according to the Diagnostic and Statistical Manual of Mental Disorder fifth edition 
(DSM-5)  diagnosis performed by a psychiatrist as required by the evaluation protocol 
for inclusion in the waiting list.  
 
- Psychometric assessments 
All subjects have been informed about the purpose of the research before giving their 
informed consent. All participants received a battery of psychometric tests consisting of a 
heteroevaluation amd self-evaluation. 
The heteroevaluation consist of: 
1. The structured clinical interview from DSM 5 (SCID 5). The SCID‐5 is organized into 
diagnostic modules, and it assesses mood disorders, psychotic disorders, substance use 
disorders, anxiety disorders, obsessive–compulsive and related disorders, eating 
disorders, somatic symptom disorders, some sleep disorders (i.e., insomnia and 
hypersomnolence disorders), “externalizing disorders” (i.e., intermittent explosive 
disorder, gambling disorder, and adult attention deficit hyperactivity disorder), and 
trauma‐ and stressor‐related disorders. It was used a version for clinicians (SCID‐CV). 
(188). 
2. The structured interview according to the Diagnostic Criteria for Psychosomatic 
Research (DCPR). The DCPR are a set of 12 psychosomatic syndromes whose 
prognostic role in the development, course and outcome of physical diseases, 
regardless of their ‘organic’ or ‘functional’ nature, was documented by a large body of 
literature. Eight of them refer to the concept of abnormal illness behaviour: persistent 
somatization, functional somatic symptoms secondary to a psychiatric disorder, 
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conversion symptoms, anniversary reaction, disease phobia, thanatophobia, health 
anxiety and illness denial. The four syndromes of alexithymia, type A behaviour, 
demoralization and irritable mood are mostly related to the field of psychological 
factors affecting medical conditions (189). The DCPR were intended as screening 
diagnoses which may supplement Axes I and II of the DSM and they may be 
integrated by dimensional tools (190). Since their introduction, the DCPR have been 
widely used in both medical (191,192) and psychiatric (193,194) settings. 
Furthermore, the DCPR syndromes were proposed to be included among the clinical 
manifestations of allostatic load (195,196). A structured interview was developed for 
the assessment of the 12 syndromes. It consists of 58 items with a dichotomous 
‘yes/no’ response format (192). Excellent inter-rater reliability, construct validity and 
predictive validity for psychosocial impairment and treatment outcome were proven 
(197,192).  
3. Mini-mental State Examination (MMSE) - Italian version: evaluation of superior 
cognitive function. Validation for italian population by Measso et al. (1993) (187). 
The Mini-Mental State Examination (MMSE) is the most common screening tool to 
assess global cognitive functioning;  As most neuropsychological tools, MMSE scores 
are influenced by demographic variables, namely age and years of education: subjects 
with higher education levels perform better than those with lower levels; moreover, 
elderly people exhibit an age-related condition, characterized by a decline in cognitive 
performances (198). 
 
The self-evaluation consist of: 
1. Kellner’s Symptom Questionnaire (SQ) – Italian version. It is a widely used 92-item 
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instrument for the measurement of the main dimensions of psychological distress: 
anxiety, depression, somatization, and hostility (199). Each scale consists of two 
sections, one relating to symptoms and one to wellbeing in the examined area. The SQ 
contains a list of 92 adjectives to answer yes/no. High scores indicate an increase in 
psychological distress. 
2. Questionnaire on the State of Health  (SF12)- Italian version by Apolone G. SF-12 
allows to describe the health according to the following scales: physical activity [PF], 
role and physical health [RP], role and emotional state [RE], mental health [MH], 
physical pain [BP], general health [GH], vitality [VT] and social activity [SF]. The 12-
item Health Survey (SF-12) was developed as a shorter alternative to the SF-36 for 
use in large-scale studies, and its reliability and validity have been documented (200). 
Scale scores are estimated for four of the health concepts (PF, RP, RE and MH) using 
two items each, whereas the remaining four (BP, GH, VT and SF) are represented by a 
single item. All 12 items are used to calculate the physical and mental component 
summary scores (PCS-12 and MCS-12) by applying a scoring algorithm empirically 
derived from the data of a US general population survey (201). Performance of the 
component summary scores was initially studied in nine languages and it has been 
recommended that the US-derived summary scores, which yield a mean of 50 and a 
SD of 10, be used in order to facilitate cross-cultural comparison of results (202). 
3. Coping Orientation to Problem Experienced – brief version by  Carver et al 1997 – 
Italian version - is a questionnaire that identifies the coping strategies: the based 
strategies on the resolution of the problem, it focuses on the emotions, or on the 
avoidance and denial of the problem. This consists of 14 scales, of two items each: 
active coping, planning, positive refraining, acceptance, humor, religion, using 
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emotional support, using instrumental support, self-distraction, denial, venting, 
substance, behavioural disengagement, self-blame. The items are divided into two 
macro areas: avoiding coping and active coping (203). 
4. Interpersonal Support Evaluation List (ISEL) by Cohen (1983) -   Italian translation by 
Grandi S. and Sirri L. (204). The ISEL measures the perceived availability of social 
support resources (205,206). The ISEL was developed in the context  of the stress 
buffering model that regards social support as a potential protective factor against 
psychological and physical distress when people have to face stressful situations 
(207). It comprises four 10-item subscales reflecting the main functions of social 
support: appraisal (availability of people one can talk to about personal problems), 
belonging (availability of someone together with one can do things), tangible 
(instrumental aid) and self-esteem (perception of a positive comparison when 
comparing oneself with others) (206). A total score, ranging from 0 to 40, can be also 
calculated. Each item can be answered ‘probably true’ or ‘probably false’. Higher 
scores correspond to a better perception of social support availability. Adequate 
validity and reliability of the ISEL were proven (208,209).  
The short form (ISEL-SF) composed by 15 items each that reflect the principal 
functions of the social support. (206)  
5. Post-traumatic Growth Scale (PTGS) - Italian version by Lawns G, Pietrantoni L. 
(2014):  it is an instrument for assessing positive outcomes reported by persons who 
have experienced traumatic events. This 21-item scale includes factors of new 
possibilities, relating to others, personal strength, spiritual change, and appreciation of 
life. The PTGS is modestly related to optimism and extraversion. The scale appears to 
have utility in determining how successful individuals, coping with the aftermath of 
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trauma, are in reconstructing or strengthening their perceptions of self, others, and the 
meaning of events. (210,211) 
6. The Gratitude Questionnaire-Six Item Form (GQ-6) by McCullough, M. E. - Italian 
version – GQ-6 Items assess experiences and expressions of gratefulness and 
appreciation in daily life, as well as feelings about receiving from others;  reflected the 
gratitude intensity facet, the gratitude frequency facet, the gratitude span facetand the 
gratitude density facet.  (212) 
The psychiatric evaluation was made by the psychiatrist consultant (M.L.R.) of the 
transplant team and the psychological assessment by the PhD Student (L.G.) and the 
principal investigator of the study (A.V.). 
 
Statistical analysis 
All samples are encoded into a dedicated database (protected by password). Descriptive 
statistical analyses are developed. Data are expressed as the mean [± standard deviation 
(sd)], median (with range) as applicable. Confidence interval (CI) is presented where 
appropriate. Wilcoxon test is utilized to assess tendencies and specific rank test for 
significance. Significant differences between variables are calculated with non-parametric 
tests. χ2 or Fisher’s exact test is used for categorical while Mann-Whitney for continuous 
variables. A p value less than 0.05 is considered significant for all tests. SPSS® software 
version 20.0 (MJ Norusis, Chicago, US) is used for all statistical analyses.  
 
Ethical approval 
The present study was approved by the Independent Ethics Committee of the University 
Hospital of Bologna, Policlinico Sant'Orsola – Malpighi, with Resolution No. 47/2017 / U 
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/ Oss of 11/04/2017. 
3.3.3 Results 
The baseline characteristics of experimental sample are reported in the Table 1, Table 2, 
Table 3 and Table 4.  
 
Table 1. Socio-demographic patterns of the enrolled patients. 
N 50 
Males n(%) 34(68) 
Age (years, mean±sd) 57±7 
Marital status n(%)  
unmarried   5(10) 
married  29 (58) 
separate/divorced  10 (20) 
cohabitant  2 (4) 
widower   4 (8) 
School attendance  
Primary school  n (%) 7 (14) 
Lower secondary  n (%) 22 (44) 
High secondary  n (%) 15 (30) 




We enrolled 50 patients at the beginning of the screening process for the LT feasibility (T0). 
In the vast part of cases, patients were males (34/50, 68%) with mean age of 57±7 years. 
Patients were married or cohabitant in 31 cases (31/50, 62%), 5 patients were unmarried 
(5/50, 10%), 10 were separated (10/50, 20%) and 4 were vidower (4/50, 8%). About school 
attendance 7 patients attended a primary school (7/50 14%), 22 attended lower secondary 







Table 2.  Psychiatric diagnosis of the enrolled patients 
 
DSM - 5 diagnosis n/n patients enrolled  10/50  
Alchohol Use Disorder n (%) 7 (14) 
Adjustment Disorder n (%) 3 (6) 





Table 3. Psychological diagnosis of the enrolled patients 
 
DCPR diagnosis n/n patients enrolled  22 /50 
Demoralization n (%) 15 (30) 
Alexythimia n (%) 6 (12) 
Irritable mood n (%) 1 (2) 




A DSM 5 diagnosis was detected in one fifth of patients, in particular 7 subjects showed an 
alcohol use disorder and 3 adjustment disorder. A DCPR syndrome was present in 22 subjects 
(44%): 15 patients displayed demoralization, 6 alexythimia, 1 irritable mood.  
 
Table 4. Psychological and psychiatric diagnosis of the enrolled patients 
 
DCPR + DSM 5 diagnosis n /n patients enrolled 6/50 
 AUD + Demoralization n (%) 3 (6) 
AUD + Alexythimia n (%) 2 (4) 
AUD + Irritable mood n (%) 1 (2) 
DCPR, Diagnostic Criteria for Psychosomatic Research 
DSM 5, Diagnostic and Statistical Manual of Mental Disorder - 5 
AUD, Alchohol Use Disorder 
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Table 4 shows the presence of double diagnosis, DSM-5 e DCPR in 6 enrolled patients: 3 
have AUD and demoralization, 2 AUD and alexitimia, 1 AUD and irritable mood. 
 
 
Table 5. Liver disease of the enrolled patients 
 
Liver disease n/ n patients enrolled (%)  
Virus  24 (48) 
Alcohol  9 (18) 
Virus+alcohol  3 (6) 
Non-alcoholic steatohepatitis 8 (16) 
Other 6 (12) 
Hepatocellular carcinoma n/n patients enrolled(%) 20 (40) 
MELD (mean±sd) 12±4 
Waiting list entering 25 (50) 
Other medical diagnosis 10(50) 
Renal failure n (%) 6 (60) 
Cardiovascular disorder n (%) 4 (40) 
MELD, model for end-stage liver disease. 
 
The main liver disease aetiology was the viral one (24/50, 48%) while hepatocellular 
carcinoma was present in 20 subjects (40%). 
Among the enrolled patients, 25 entered in to the waiting list for LT. 












































































SD, standard deviation; SF, 12-item Health Survey (SF-12); PCS, Physical Component Score; MCS, Mental 
Component Score; SQ, Symptom Questionnaire; BC, Brief Cope; ISEL, Interpersonal Support Evaluation List 
 
 
The median values of patients were in the mid-range of the regulatory sample for the scale of 
physical function and the scale of mental functioning. Enrolled subjects showed anxiety, 
depression, somatic symptoms scores lower than the norm sample value. Furthermore, 
patients displayed greater values concerning the scale of hostility. 
The patients reported al lower score than norm sample related to the gratitude scale. 
Then we developed a subanalysis of the questionarries’ score according to the main social and 
clinical registered factors that a priori might impact the scores themselves. 
Especially, in the Table 6a we subdivided patients according to gender finding that females 
displayed a score of BC emotional support significantly higher than males (p=0.001). 
Survey Score (median, min-max) 
SF12 PCS 43, 21-58 
SF12 MCS 46, 24-59 
SQ anxiety 5, 0-14 
SQ depression 5, 1-18 
SQ somatic symptom 9, 0-18 
SQ hostility 3, 0-15 
BC positive refraining 5, 2-8 
BC self distraction 5, 2-8 
BC venting 4, 2-6 
BC instrumental support 4, 2-8 
BC active coping 5, 2-8 
BC denial 3, 2-7 
BC religion 3, 2-8 
BC humor 3, 2-8 
BC behavioural disengagement 3, 2-7 
BC emotional support 4, 2-8 
BC substances use 2, 2-5 
BC acceptance 6, 2-8 
BC planning 5, 2-8 
BC self-blame 4, 2-7 
ISEL 23, 14-39 
Post traumatic growth 38, 8-85 
Gratitude 30, 20-42 
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Table 7a. Comparison between enrolled patients (T0) according to gender. 
 
 
SD, standard deviation; χ2, Chi-Square test; MW-U, Mann-Whitney U test 
SF, 12-item Health Survey (SF-12); PCS, Physical Component Score; MCS, Mental Component Score; SQ, 
Symptom Questionnaire; BC, Brief Cope; ISEL, Interpersonal Support Evaluation List 
 
 
In the Table 6b we considered the questionarries subdividing the cohort in patients with or 
without husband/wife//cohabitant. Subjects of the first subgroup showed an SQ hostility 





 Males Females   P value 
(MW-U) 
Survey score (median, min-max) N=34 N=16 P value 
SF12 PCS 44, 22-58 41, 21-55 0,533 
SF12 MCS 47, 24-59 43, 30-57 0,190 
SQ anxiety 4, 1-14 5, 0-9 0,983 
SQ depression 5, 1-18 7, 1-10 0,483 
SQ somatic symptom 9, 0-18 9, 2-14 0,826 
SQ hostility 3, 0-15 3, 0-12 0,761 
BC positive refraining 5, 2-8 5, 3-8 0,873 
BC self distraction 4, 2-8 5, 2-8 0,166 
BC venting 4, 2-6 4, 2-6 0,155 
BC instrumental support 4, 2-7 5, 3-8 0,175 
BC active coping 5, 2-8 6, 3-8 0,220 
BC denial 3, 2-6 4, 2-7 0,200 
BC religion 2, 2-8 3, 2-8 0,298 
BC humor 3, 2-8 3, 2-6 0,684 
BC disengagement 3, 2-7 3, 2-6 0,721 
BC emotional support 4, 2-8 5, 4-8 0,001 
BC substances use 2, 2-5 2, 2-3 0,817 
BC acceptance 6, 2-8 6, 2-8 0,584 
BC planning 5, 2-8 5, 3-8 0,808 
BC self-blame 4, 2-7 4, 2-6 0,472 
ISEL 25, 15-39 21, 14-36 0,559 
Post traumatic growth 36, 0-85 47, 8-84 0,441 
Gratitude 29, 20-42 33, 23-42 0,189 
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Table 7b. Comparison between enrolled patients (T0) according to marital status. 
 
SD, standard deviation; χ2, Chi-Square test; MW-U, Mann-Whitney U test 
SF, 12-item Health Survey (SF-12); PCS, Physical Component Score; MCS, Mental Component Score; SQ, 
Symptom Questionnaire; BC, Brief Cope; ISEL, Interpersonal Support Evaluation List 
 
 Married/Cohabitant Unmarried/Separed/Widower P value 
(MW-U) 
Survey score (median, min-max) N=31 N=19 P value 
SF12 PCS 44, 22-58 38, 21-55 0,678 
SF12 MCS 46, 30-59 45, 28-59 0,717 
SQ anxiety 5, 1-14 4, 0-14 0,182 
SQ depression 5, 1-11 4, 1-10 0,473 
SQ somatic symptom 7, 0-18 10, 2-15 0,055 
SQ hostility 3, 0-15 1, 0-15 0,030 
BC positive refraining 5, 2-8 5, 3-8 0,237 
BC self distraction 5, 2-8 5, 2-8 0,616 
BC venting 4, 2-6 3, 2-6 0,641 
BC instrumental support 4, 2-8 4, 2-8 0,512 
BC active coping 5, 2-8 5, 3-8 0,589 
BC denial 3, 2-6 3, 2-7 0,904 
BC religion 3, 2-8 2, 2-8 0,280 
BC humor 3, 2-8 3, 2-6 0,758 
BC disengagement 3, 2-6 2, 2-6 0,316 
BC emotional support 4, 2-8 4, 2-8 0,840 
BC substances use 2, 2-3 2, 2-3 0,530 
BC acceptance 6, 2-8 5, 2-8 0,364 
BC planning 6, 2-8 5, 4-8 0,616 
BC self-blame 4, 2-6 4, 2-6 0,789 
ISEL 23, 14-39 23, 15-35 0,846 
Post traumatic growth 36, 0-85 53, 3-85 0,143 
Gratitude 31, 23-42 31, 25-40 0,696 
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As shown in Table 6c, there are many differences between patients with and without 
diagnosis of AUD. Subjects with AUD showed higher BC humor, Post traumatic growth and 
Gratitude score than patients without AUD (p=0.049, p=0003, p=0.013, respectively). 
 
Table 7c. Comparison between enrolled patients (T0) according to diagnosis of 




SD, standard deviation; χ2, Chi-Square test; MW-U, Mann-Whitney U test 
SF, 12-item Health Survey (SF-12); PCS, Physical Component Score; MCS, Mental Component Score; SQ, 
Symptom Questionnaire; BC, Brief Cope; ISEL, Interpersonal Support Evaluation List 
AUD, alcohol use disorder 
 
 
Finally, we compared baseline questionarries according to the presence of HCC (Table 6d) 
demonstrating that patients with cancer had higher SF12 MCS and Post traumatic growth in 
 AUD No-AUD P value (MW-U) 
Survey score (median, 
min-max) 
N= 7 N=43 P value 
SF12 PCS 48, 36-58 40, 21-56 0,086 
SF12 MCS 46, 39-58 47, 24-59 0,989 
SQ anxiety 8, 0-14 4, 1-14 0,175 
SQ depression 8, 1-10 5, 1-18 0,167 
SQ somatic symptom 9, 0-18 8, 1-18 0,330 
SQ hostility 4, 0-15 2, 0-15 0,304 
BC positive refraining 7, 4-8 5, 2-8 0,175 
BC self distraction 5, 4-8 5, 2-8 0,550 
BC venting 3, 2-6 4, 2-6 0,604 
BC instrumental support 5, 4-6 4, 2-8 0,401 
BC active coping 5, 2-8 6, 2-8 0,989 
BC denial 4, 2-5 5, 2-7 0,681 
BC religion 3, 2-8 2, 2-8 0,304 
BC humor 5, 2-6 3, 2-8 0,049 
BC disengagement 3, 2-6 3, 2-6 0,586 
BC emotional support 4, 2-8 4, 2-8 0,905 
BC substances use 2, 2-23 2, 2-5 0,586 
BC acceptance 5, 2-28 6, 2-8 0,568 
BC planning 5, 4-8 5, 2-8 0,781 
BC self-blame 4, 3-7 4, 2-7 0,109 
ISEL 25, 17-36 23, 14-39 0,448 
Post traumatic growth 70, 33-85 36, 0-85 0,003 
Gratitude 34, 29-42 30, 20-42 0,013 
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comparison to the other patiens (p=0.021, p=0.003, repsetively). Furthermore, patients with 
HCC displayed lower value in the following questionarries: SQ depression, BC self 
distraction, BC instrumental support, BC religion, BC behavioural disangagement and 
Gratitude (p=0.042, p=0.017, p=0.036, p=0.007, p=0.048, p=0.042, respectively). 
 





SD, standard deviation; χ2, Chi-Square test; MW-U, Mann-Whitney U test 
SF, 12-item Health Survey (SF-12); PCS, Physical Component Score; MCS, Mental Component Score; SQ, 
Symptom Questionnaire; BC, Brief Cope; ISEL, Interpersonal Support Evaluation List 




 HCC No-HCC P value (MW 
U) 
Survey score (median, min-max) N=20 N=30 P value 
SF12 PCS 42, 21-56 43, 24-59 0,560 
SF12 MCS 48, 30-59 43, 24-59 0,021 
SQ anxiety 4, 1-10 5, 0-14 0,442 
SQ depression 4, 1-18 7, 1-11 0,042 
SQ somatic symptom 7, 1-18 9, 0-18 0,229 
SQ hostility 3, 0-12 3, 0-15 0,705 
BC positive refraining 5, 2-8 5, 3-8 0,784 
BC self distraction 3, 2-7 5, 2-8 0,017 
BC venting 4, 2-6 4, 2-6 0,356 
BC instrumental support 4, 2-7 5, 2-8 0,036 
BC active coping 4, 2-8 6, 2-8 0,290 
BC denial 3, 2-6 4, 2-7 0,798 
BC religion 2, 2-7 3, 2-8 0,007 
BC humor 3, 2-8 4, 2-6 0,333 
BC disengagement 2, 2-6 4, 2-7 0,048 
BC emotional support 4, 2-6 4, 2-8 0,234 
BC substances use 2, 2-5 2, 2-5 0,081 
BC acceptance 5, 2-8 6, 2-8 0,695 
BC planning 5, 2-8 5, 3-8 0,506 
BC self-blame 4, 2-7 4, 2-7 0,177 
ISEL 24, 15-39 22, 14-36 0,789 
Post traumatic growth 32, 0-80 22, 3-80 0,003 
Gratitude 27, 0-37 33, 20-42 0,043 
	 49	
Enrolled patients were socio-demographic variables, gender- and age-matched with general 
population (control group). As reported in Table 7, control cohort showed higher scores in 
both scales  (PCS, MCS) of SF-12 (p=0.000, p=0.000, respectively), in BC positive 
refraining, BC venting, BC instrumental support, BC humor, BC behavioural disengagement, 
BC emotional support, BC self-blame (p=0.000, p=0.000, p=0.000, p=0.000, p=0.001, 
p=0.000, p=0.000, individually) and in the ISEL and PTG Scale (p=0.000, p=0.000, 
respectively). 
Experimental group reported higher scores in the scale of SQ about anxiey, depression and 
somatic symptom (p=0.004, p=0.000, p=0.000, individually). Moreover, higher BC substance 




Table 8. Comparison between enrolled patients (T0) and matched general population. 
 
 
SD, standard deviation; χ2, Chi-Square test; MW-U, Mann-Whitney U test 
SF, 12-item Health Survey (SF-12); PCS, Physical Component Score; MCS, Mental Component Score; SQ, 
Symptom Questionnaire; BC, Brief Cope; ISEL, Interpersonal Support Evaluation List 
 
 Experimental Control P value 
(χ2/MW-U) 
Characteristic N=50 N=50 P value 
Males n (%) 34 (68) 34 (68) 1,000 
Age (years, mean±sd) 57±7 58±8 0,679 
Survey score (median, min-max)    
SF12 PCS 43, 21-58 54, 33-59 0,000 
SF12 MCS 46, 24-59 54, 31-60 0,000 
SQ anxiety 5, 0-14 3, 0-14 0,004 
SQ depression 5, 1-18 3, 1-11 0,000 
SQ somatic symptom 9, 0-18 4, 0-17 0,000 
SQ hostility 3, 0-15 3, 0-10 0,629 
BC positive refraining 5, 2-8 7, 2-8 0,000 
BC self distraction 5, 2-8 5, 2-7 0,208 
BC venting 4, 2-6 5, 4-7 0,000 
BC instrumental support 4, 2-8 6, 3-8 0,000 
BC active coping 5, 2-8 5, 4-8 0,491 
BC denial 3, 2-7 3, 2-7 0,354 
BC religion 3, 2-8 3, 2-8 0,201 
BC humor 3, 2-8 5, 2-7 0,000 
BC disengagement 3, 2-7 5, 2-7 0,001 
BC emotional support 4, 2-8 6, 2-8 0,000 
BC substances use 3, 2-5 2, 2-4 0,005 
BC acceptance 6, 2-8 5, 2-8 0,992 
BC planning 5, 2-8 5, 3-8 0,589 
BC self-blame 4, 2-7 6, 3-8 0,000 
ISEL 23, 14-39 36, 23-40 0,000 
Post traumatic growth 38, 8-85 56, 20-88 0,000 
Gratitude 30, 20-42 28, 28-42 0,280 
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3.4 Study 2  
3.4.1 Objective 
The aim of the study 2 was to observe the changes of psychological variables from the 
beginning of pre-LT screening (T0) to the entrance in the waitlist for LT (T1).  
3.4.2 Methods 
The first psychometric evaluation (T0), which took place during the screening phase for 
suitability for LT, was followed by a second evaluation carried out at the time of signing the  
Informed Consent for the active inclusion on the waiting list for LT (T1). 
Of the 50 patients enrolled in T0, 25 patients were placed on the waiting list completing the 
second study time point (T1); 21 patients came out from the study; in particular, 2 patients 
died before listing, 17 resulted not-transplantable (4 for improvement of illness, 13 for 
worsening), 2 were transferred to other Transplant Centre;  4 patients was still being screened. 
The same battery of tests was administered to this group of patients and the same exclusion 
criteria were considered. 
 
- Psychometric assessment 
All subjects were given a battery of psychometric tests consisting of heteroevaluatione and 
self-evaluation. 
The heteroevaluation consist of: 
1. The structured clinical interview from DSM 5 (SCID5). 
2. The structured interview according to the Diagnostic Criteria for Psychosomatic 
Research (DCPR). 
3. Mini-mental State Examination (MMSE). 
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The self-evaluation concern: 
1. Kellner’s Symptom Questionnaire (SQ). 
2. The 12-item Health Survey (SF-12). 
3. Coping Orientation to Problem Experienced (brief version) (Brief –COPE). 
4. Interpersonal Support Evaluation List (ISEL). 
5. Post-traumatic Growth Scale. 
6. The Gratitude Questionnaire-Six Item Form (GQ-6). 
 
Statistical analysis 
All samples are encoded into a dedicated database (protected by password). Descriptive 
statistical analyses are developed. Data are expressed as the mean [± standard deviation (sd)], 
median (with range) as applicable. Confidence interval (CI) is presented where appropriate. 
Wilcoxon test is utilized to assess tendencies and specific rank test for significance. 
Significant differences between variables are calculated with non-parametric tests. χ2 or 
Fisher’s exact test is used for categorical while Mann-Whitney for continuous variables. A p 
value less than 0.05 is considered significant for all tests. SPSS® software version 20.0 (MJ 
Norusis, Chicago, US) is used for all statistical analyses.  
 
Ethical approval 
The present study was approved by the Independent Ethics Committee of the University 
Hospital of Bologna, Policlinico Sant'Orsola – Malpighi, with Resolution No. 47/2017 / U / 




Changes of DSM – 5 and DCPR dignosis from screening (T0) to waitlist entrance (T1) were 
reported in Table 8 and in Table 9. 
 
 
Table 9. Trends of DSM – 5 diagnosis from screening (T0) to waitlist entrance (T1) 
 
 T0 T1 
DSM -5 diagnosis n/total patient(%) 10 /50 (20) 13/25 (52) 
Alchohol Use disorder n (%) 7 (4) 7 (28) 
Adjustment disorder n (%) 3 (6) 4 (16) 
Generalized anxiety disorder n(%) 0 (0) 2 (8) 
 
DSM 5, Diagnostic and Statistical Manual of Mental Disorder - 5 
 
 
Table 10. Trends of DCPR diagnosis from screening (T0) to waitlist entrance (T1) 
 T0 T1 
DCPR diagnosis n/total patient (%)  22/50 (44)  24/25 (96) 
Demoralization n (%) 15 (30) 15 (60) 
Alexythimia n (%) 6 (12) 6 (24) 
Irritable mood n (%) 1 (2) 3 (12) 
 
DCPR, Diagnostic Criteria for Psychosomatic Research 
 
From T0 to T1, there is an increase of DSM-5 and DCPR diagnosis. At T1, 4 patients 
reported a adjustment disorder, 2 patients generalyzed anxiety disorder, and 3 irritable mood. 








Table 11. Psychological and psychiatric diagnosis at T1 
 
DCPR + DSM 5 diagnosis n /n patients enrolled 7/25 
 AUD + Demoralization n (%) 3 (12) 
AUD + Alexythimia n (%) 1 (4) 
AUD + Irritable mood n (%) 2 (8) 
Generalized anxiety disorder + Irritable mood n (%) 1 (4) 
DCPR, Diagnostic Criteria for Psychosomatic Research 
DSM 5, Diagnostic and Statistical Manual of Mental Disorder - 5 
AUD, Alchohol Use Disorder 
 
 
Table 11 shows the presence of double diagnosis, DSM-5 e DCPR in 7  patients at T1: 3 have 
AUD and demoralization, 1 AUD and alexitimia, 2 AUD and irritable mood, 1 Generalized 
anxiety disorder and irritable mood. 
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Table 12. Trends of questionarries’ scores from screening (T0) to waitlist entrance (T1). 
 
 
SD, standard deviation; χ2, Chi-Square test; MW-U, Mann-Whitney U test 
SF, 12-item Health Survey (SF-12); PCS, Physical Component Score; MCS, Mental Component Score; 
SQ,Symptom Questionnaire; BC, Brief Cope; ISEL, Interpersonal Support Evaluation List 
 
There were no statistically significant differences between T0 and T1. However, considering 
SQ Hostility subscale, 12 of 25 patients report higher scores at T1 in respect to T0 (p=0.084); 
contemplating BC Self distraction subscale, 14 of 25 subjects showed higher score at T1 in 
comparison with T0 (p=0.079). 
 
3.5 Discussion 
LT is an effective treatment option for patients with acute liver failure, end-stage liver disease 
and HCC (169). LT has not only a relevant positive impact of patients’ survival but also on 
the QoL (179).  
Survey score (median, min-max) T0 T1 N patients’ modifications Wilcoxon Test P value 
   increase decrease equal  
SF12 PCS 43, 22-54 45, 24-56 16 7 1  0,429 
SF12 MCS 49, 24-59 45, 23-60 9 15 0     0,199 
SQ anxiety 5, 1-14 6, 1-14 14 8 2 0,177 
SQ depression 5, 1-18 6, 0-14 13 10 1 0,252 
SQ somatic symptom 10, 2-18 10, 0-21 10 11 3 0,917 
SQ hostility 2, 0-11 5, 0-13 12 6 6 0,084 
BC positive refraining 5, 2-8 5, 3-8 8 13 3 0,669 
BC self distraction 4, 2-8 5, 2-8 14 6 4 0,079 
BC venting 4, 2-6 4, 2-7 13 7 4 0,389 
BC instrumental support 4, 2-7 4, 2-8 11 8 5 0,363 
BC active coping 6, 3-8 6, 2-8 10 9 5 0,984 
BC denial 4, 2-7 2, 2-8 6 9 9 0,438 
BC religion 3, 2-8 2, 2-7 7 9 8 0,772 
BC humor 3, 2-8 4, 1-8 10 8 6 0,273 
BC disengagement 3, 2-6 3, 2-8 10 8 6 0,790 
BC emotional support 4, 2-8 3, 2-8 8 12 4 0,363 
BC substances use 2, 2-5 2, 2-5 2 6 15 0,518 
BC acceptance 6, 3-8 6, 4-8 14 7 3 0,351 
BC planning 5, 3-8 5, 3-8 10 11 3 0,874 
BC self-blame 4, 2-7 5, 2-6 12 9 3 0,113 
ISEL 26, 15-39 28, 15-51 14 8 2 0,101 
Post traumatic growth 39, 8-80 37, 5-84 10 12 2 0,897 
Gratitude 30, 20-40 28, 21-39 10 13 1 0,337 
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However the post-transplant rehabilitation process requires a psychological adaptation to the 
new condition of life. Notably, the strong need to follow specific therapeutic regimens 
(pharmacological and behavioral), the risk of rejection and infections and the clinical 
complications secondary to immunosoppressive therapy, can determine a lower psychological 
adaptation of the patient (155). 
The presence of psychological distress and psychiatric disorders and the difficulty in coping 
with the stress of the transplant experience, can compromise the LT outcome mainly reducing 
the therapeutic adherence (181-182). 
On the basis of the scientific evidence, the present research has been divided into two studies. 
We tried to focus on the complexity of the transplant process. Indeed, we studied the phases 
of the transplant path to which correspond phases of psychological adaptation. 
Concerning the enrolled population, among the 50 patients, only 25 completed the first step 
(T1). This may indicate that there was a high rate of patients for which the screening process 
has started too soon or too late.  
This study investigated specifically the first step of LT process represented by the pre-LT 
screenig (T0 of the study). This is a relatively long period (generally form 1 to 3 months) 
during which patients undergo to an amount of exams that definitely need to exclude 
contraindications fo the transplant itself. According to the above described concept (necessity 
of adaptation to the new condition of life), we reported that patients at T0 often showed 
DCPR diagnosis such as demoralization, alexithymia and irritable mood. 
Alexithymia has been the object of a large body of psychosomatic literature and its role is 
being examined in an ever-increasing number of diseases. Although its prognostic value 
needs to be further clarified, alexithymia was linked to a worsened outcome of  medical 
conditions, such as cardiovascular diseases, cancer and gastrointestinal disorders. Alexithymia 
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was also significantly associated with substance abuse and disordered eating and altered 
immune responses to stress (189).  
Demoralization may precede the onset of medical diseases and is triggered by the experience 
of the disease (189). 
The characteristics of demoralization had been descripted by Schmale and Engel’s (1967) 
descripted as the ‘giving up– given up complex’. Subjects with the giving up– given up 
complex experience feelings of helplessness and hopelessness, diminished perception of com- 
petence and control, loss of sense of continuity between past and future and impairments in 
their interpersonal relationships. They are led to relive previous failed or frustrating 
experiences and feel that personal performance or the environment does not meet their 
expectations (8). 
Demoralization and hopelessness, one of its most relevant features, were significantly 
associated with both onset and worsened outcome of cancer and car- diovascular diseases 
(213). 
We have divided the sample according to variables that a priori can impact the psychological 
status at the time of screening for LT. In particular, gender does not seem to be a significant 
element of change. Females showed a statistically higher value in the BC Emotional support 
scale in comparison with males. Therefore, it is possible that females were able to develop a 
coping strategy associated with more useful responses to adversity (including adaptive 
practical adaptation), better results on physical health and a more stable emotional response in 
comparison with males (129). 
In our study, a positive correlation emerges between the marital status and the presence of 
anger / hostility at the time of screening for LT. It is important to deal with transplantation 
with a nearby caregiver, but the status of “patient” imposes a restructuring of both social and 
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emotional relationships. The status of “patient” might be a trigger of a time-consuming 
adaptation process and could be related to both anger and hostility (95-99). 
Hepatitis C virus (HCV) infection may affect the QoL even in absence of advanced cirrhosis 
showing a harmful impact on both mental health and physical well-being (108-109). HCV 
positive patients often develop fatigue, irritability, general discomfort, abdominal pain, joint 
pain and headache that may deteriorate both general psychological status and QoL (213). 
HCV can negatively modify also the post-LT condition since HCV positive recipients can 
develop higher rates of depression symptoms in comparison with other etiologies (112). 
Similar concepts exist for patients with alcohol habit although they show great long-term 
post-LT outcomes (173).  
AUD is associated in about 30% of cases with mood disorder (113,114). Nevertheless, it has 
been suggested that etiology of liver disease is not the main predictor of altered mental status 
during the staying on waitlist. Remarkably, the presence of negative and passive coping 
behavior such as an acceptance-resignation strategy represents a leading cause of mental 
health impairment. In particular, it determines an altered insight of physical functioning and a 
fall of global QoL (115).  
In our study, patients with AUD at T0 point time reported use of humor as a coping strategy 
more than patients without AUD. Furtermore, patients with AUD showed poor perception of 
social support. Active coping, social support and interdisciplinary approach might help 
patients to achieve psychological positive change after LT (164). The importance of social 
support has been confirmed in many transplant settings including LT (147). In fact, LT 
candidates with anxious family members tend to use to a lesser extent successful coping 
strategies such as active fighting, self-control/emotional control and seeking for social support 
(165). Caregivers of LT candidates often display psychological stress such as doubts about 
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emergency situations (42.6%), mood swings (29.5%), food and medications (27.9%). In 
general, about 25% of caregivers feel themselves inadequate for their role. Due to the 
importance of the social support, caregiver-dedicated training might be applied in all 
transplant centers (166). In this context, multidisciplinary team should help patients to 
develop positive attitude toward transplant process. 
Among enrolled patients, it has to be underlined that the prevalence of HCC (40%) and viral 
etiology (48%) is coherent respect to literature (172). The cancer per se can negatively 
influence the psychological status being a relevant independent factor of psychological 
distress (214). In our study, patients with HCC in respect to the others, displayed lower levels 
of depression and lower use of self distraction and behavioral disengagement coping and 
higher sense of gratitude in respect to patients without cancer. These findings might indicate 
that the presence of HCC could be a trigger to effective coping the illness but this should be 
confirmed through dedicated studies.  
Data from the study 1 showed that control group (general population) had a better perceived 
state of health and a tendentially active coping than the patients group. This data could be a 
confirm of the difficult process of adaptation linked to the transplant path, since its early steps 
(screening and waiting list) (174-176). 
According to literature data, patients in pre-LT screening report anxiety, depression and 
somatic symptoms (177). 
In the evaluation of the transplant candidate, the possibility of patient’s under-reporting them 
must be considered. Patients might anticipate that if they report high levels of 
psychopathology and/or alcohol issues this might prejudice them in terms of getting on the 
transplant list. Patients have their own theories as to why staff are assessing their mental 
health and may alter their responses based on these (113,114).   
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In study 2, the evaluation of trends from T0 to T1, does not reveal statistically significant 
differences about psychological variables. This can be explained mainly by the relative short 
time between the two time points and the low sample size. However, an increase in scores can 
be seen in the hostility symptom and in the self-distraction coping.  
For patients in pre-LT screening, inclusion on the waitlist is the beginning of a real path 
toward the transplantation, which definitely represents a chance of a new life. However, 
listing is often associated with worsening liver disease, physical and psychological 
deterioration. Coherently, in our study, we registered an increase of diagnoses of DSM and 
DCPR from T0 and T1.  
From T0 to T1, we did not detect significant differences in positive psychological indices, 
post traumatic growth and gratitude. These indices seem to be related to the LT rather than 
enter in the waitlist since LT itself represents a true transformed event.  
Our data support the importance of multidisciplinary approach in the management of the 
patients during the entire transplant process. 
Our study shows some limitations. First of all the small sample size. Patients undergo many 
screening examinations and some are excluded for the emergence of medical comorbidities 
and, as a result, are no longer included in the waiting list criteria. 
So, it could also be useful to increase the sample to think of a multicenter study.  
Secondly, the relatively short time period of observation limited to the first two steps of LT 
process. We suggest the needing of further multicenter studies to confirm our data and to 
analyze all the LT stages. This appears as the only feasible approach to plan an early 
diagnosis, an effective therapy and a whole social, psychological and clinical support for 
patients.  
Since research found an increase in psychological distress and psychosomatic factors in a 
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small number of patients over the time period involved, in the future a useful addition to the 
research might have to include a qualitative dimension, in particular, to interview those 
patients who experienced negative changes. This could identified in more detail what actually 
happened for those individuals. 
The present research program could have important practical implications. The identification 
of psychological, psychiatric and psychosomatic predictors of long-term clinical outcome 
may lay the basis for the development of psychological strategies aimed at improvement the 
clinical course of LT through the modulation of psychological risk factors. 
The modification of psychological risk factors through specific psychotherapeutic strategies 
(cognitive-behavioral therapy, life-style modification, stress management, relaxation training, 
motivational interviewing, acceptance and commitment therapy, compassion focused therapy) 
may results in the improvement of LT recipients' psychological adjustment (reduction of 
psychological distress and allostatic load), patients' adherence to medical therapies 
(pharmacological therapies, healthy life-style), patients' clinical course (less re-
hospitalization, relapses, morbidities). 
On the other side, the identification of clinical and instrumental predictors of quality of life 
may lay the basis for the detection of those LT recipients at a higher risk of inadequate 
psychological adjustment and who deserve specific psychotherapeutic interventions. 
Another useful addition to the study could be to to ask at least a subset of participants how 
they experienced being given such an extensive battery of psychometric tests and screening 
measures. For example, how acceptable is it for patients to complete numerous psycho-metric 
measures, did any find it off-putting, impersonal or distressing? Enquiring about this could 




Main aim of LT should be to lengthen life expectancy beyond the natural history of 
underlying liver disease (with achievement of so called “transplant benefit”) but also to 
improve patients’ quality of life (QoL). Patients should be designated if estimated survival in 
the absence of LT is 1 year or less, or if the patient had an unacceptable QoL because of liver 
disease. A detailed medical evaluation is performed to ensure the feasibility of LT (pre-LT 
screening). 
The ideal moment for referring patients to Transplant Center is the first decompensation of 
liver disease (variceal bleeding, ascites, hepatorenal syndrome and encephalopathy). On the 
other hand, acute liver failure is an urgent indication to LT (70). 
The goal of transplantation should not be only to enhance patients’ survival, but also to offer 
the same state of health that they enjoyed before the onset of liver disease. This complex 
achievement can be reach through a balance between the functional efficiency of the graft and 
the patient’s psychological and physical integrity (87,88). 
Analysis of literature on psychological, psychosomatic and psychiatric correlates LT 
highlighted the presence of several publications on the QoL and psychiatric morbidity of 
patients included in the Transplant Program. 
Studies and transplant guidelines (107) suggest the importance of psyhcological and 
psychiatric evaluation in the setting of LT. In fact, it has been documented that the presence 
of some psychosocial problems in the pre-transplant period might have negative prognostic 
impact on the transplant outcome. 
LT includes a complex and articulated clinical process (98). Candidates waiting for LT by 
definition present life-threatening disease needing donor organ for surviving (100,101). When 
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the organ becomes available, patients undergo major surgery and then they have to bear short 
or long intensive care unit hospitalization. After LT, recipients should adapt to 
immunosuppressive drugs and restrictive life-style rules. 
Also the etiology of liver disease is a relevant risk factor for impairment QoL and mental 
disorder. It is well known that HCV can alter the QoL showing deleterious impact on mental 
health and physical well-being (108,109). 
Also subjects with alcohol-related liver disease deserve specific selection (113-114). 
So the predictive aptitude of pre-transplant psychiatric and psychological factors is actually 
debated. However, seeing the impact of psychological variables on the entire transplant 
process, major scientific attention should be deserved to this complex topic. 
Notably, achievement of survival benefit and return to satisfying QoL should represent the 
main goals of transplantation. In fact, transplant recipients should obtain the health status that 
they had before the onset of liver disease with a complex steadiness between graft 
functionality and recipient integrity (215). Psychological support within a multi-disciplinary 
team is a powerful tool to achieve these aims. Only a multi-disciplinary transplant team can 
guarantee an effective holistic orientation towards patients		(216).  
Seeing the relationship between psychosocial patterns and clinical outcome, the 
multidisciplinary methodology represents the only rational ways to achieve a global benefit 
(217).  
We well know that psychological status of LT candidates might influence post-LT adherence, 
QoL and clinical outcome. Many psychosocial factors can influence the transplant process. 
As we demonstrated, in the early phases of Transplant process, patients already show many 
patterns of psychosomatic distress needing a prompt psychological support. Notably, 
Schneekloth et al. (218) suggested the prominence of the pre-LT psychological assessment. 
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We also demonstrated a worsening of many psychosomatic and psychiatric patterns from the 
first phase of Transplant Process to the enter in the waiting list. This is a very complex period 
since it can have a very variable length. Moreover, every step of the pre-LT screening can 
represent a turning point for the possible detection of a contraindication for transplant itself. 
Indeed, it is not surprising that deterioration can be registered. However, our data suggest and 
confirm the relevance of an early intervention. 
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